UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000045109
Receipt No. R000051496
Scientific Title A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease
Date of disclosure of the study information 2021/08/12
Last modified on 2022/08/16 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease
Acronym A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease
Scientific Title A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease
Scientific Title:Acronym A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease
Region
Japan

Condition
Condition N/A
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study examine the association between risk markers of lifestyle-related diseases and blood parameters
Basic objectives2 Others
Basic objectives -Others N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The association between risk markers of lifestyle-related disease and blood parameters
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria (1) Healthy male and female subjects (>=40 to >70 years of age)
(2) Subjects whose BMI values are between normal-high and obesity class 1 (>=23 to <30 kg/m2)
(3) Subjects whose fasting blood glucose levels are <126 mg/dL and 2-hour blood glucose levels are <200 mg/dL during oral glucose tolerance test
(4) Subjects who participate in this study with a written informed consent
Key exclusion criteria (1) Subjects who have dietary carbohydrate restriction and try to lose weight or who plan to have dietary carbohydrate restriction and lose weight during the scheduled study period
(2) Subjects who consecutively intake pharmaceutical and healthcare foods (which is possible to influence the results of this study) at 3 or more times per week
(3) Subjects who plan to change their daily habit (diet, exercise) and living environment (changing residence, employee relocation, et al.) during the scheduled study period
(4) Subjects with extremely irregular dietary habits
(5) Subjects with excessive alcohol intake
(6) Subjects with excessive smoking
(7) Subjects who are positive for hepatitis C virus antibody or hepatitis B surface antigen
(8) Subjects who allergies to medication or foods (especially soybean and gelatin)
(9) Subjects who are participating in another trial, have participated in the past 4 weeks, or plan to participate in another trial during the scheduled study period
(10) Females who have pregnancy, lactation, plan to have pregnancy
(11) Subjects who receive medical treatment or have a history of severe disease
(12) Subjects who have made a platelet donation or a blood donation of 200 mL within one month prior to this study
(13) Males who have made a blood donation of 400 mL within three months
(14) Females who have made a blood donation of 400 mL within four months
(15) Males who have made a blood donation over an amount (1200 mL minus the estimated volume of blood collected during to this study) within one year prior to this study
(16) Females who have made a blood donation over an amount (800 mL minus the estimated volume of blood collected during to this study) within one year prior to this study
(17) Subjects judged to be unsuitable for the study for other reasons by the investigators
Target sample size 440

Research contact person
Name of lead principal investigator
1st name Yoshihiro
Middle name
Last name Yamamoto
Organization House Wellness Foods Corporation
Division name Research & Development Institute
Zip code 664-0011
Address Imoji 3-20, Itami, Hyogo, Japan
TEL 072-778-1127
Email Yamamoto_Yoshihiro@house-wf.co.jp

Public contact
Name of contact person
1st name Ryusei
Middle name
Last name Uchio
Organization House Wellness Foods Corporation
Division name Research & Development Institute
Zip code 664-0011
Address Imoji 3-20, Itami, Hyogo, Japan
TEL 072-778-1127
Homepage URL
Email Uchio_Ryusei@house-wf.co.jp

Sponsor
Institute Research & Development Institute, House Wellness Foods Corporation
Institute
Department

Funding Source
Organization House Wellness Foods Corporation
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Chiyoda Paramedical Care Clinic
Address 2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan
Tel 03-5297-5548
Email IRB@cpcc.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 08 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 431
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2021 Year 06 Month 18 Day
Date of IRB
2021 Year 06 Month 18 Day
Anticipated trial start date
2021 Year 08 Month 12 Day
Last follow-up date
2021 Year 08 Month 26 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information None

Management information
Registered date
2021 Year 08 Month 10 Day
Last modified on
2022 Year 08 Month 16 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051496